Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMOTE
NCT07848477Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Oct 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Prucalopride with Placebo (2 arms). Primary endpoint: Auditory Verbal Learning Test at Day 14. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
prucalopride
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07848477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848477.